IL50250A0 - Pharmaceutical base salts of a polymer containing acid - Google Patents

Pharmaceutical base salts of a polymer containing acid

Info

Publication number
IL50250A0
IL50250A0 IL50250A IL5025076A IL50250A0 IL 50250 A0 IL50250 A0 IL 50250A0 IL 50250 A IL50250 A IL 50250A IL 5025076 A IL5025076 A IL 5025076A IL 50250 A0 IL50250 A0 IL 50250A0
Authority
IL
Israel
Prior art keywords
polymer containing
containing acid
base salts
pharmaceutical base
pharmaceutical
Prior art date
Application number
IL50250A
Other versions
IL50250A (en
Original Assignee
Hydrophilics Int Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB3529575A external-priority patent/GB1563390A/en
Application filed by Hydrophilics Int Inc filed Critical Hydrophilics Int Inc
Publication of IL50250A0 publication Critical patent/IL50250A0/en
Publication of IL50250A publication Critical patent/IL50250A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/58—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
IL50250A 1975-08-27 1976-08-12 Sustained release compositions comprising slats of pharmaceutically acitve bases with polymers containing acid groups IL50250A (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB3529575A GB1563390A (en) 1975-08-27 1975-08-27 Pharmaceutical products
GB3529675 1975-08-27
GB2396276 1976-06-10
GB2396376 1976-06-10

Publications (2)

Publication Number Publication Date
IL50250A0 true IL50250A0 (en) 1976-10-31
IL50250A IL50250A (en) 1980-01-31

Family

ID=27448608

Family Applications (1)

Application Number Title Priority Date Filing Date
IL50250A IL50250A (en) 1975-08-27 1976-08-12 Sustained release compositions comprising slats of pharmaceutically acitve bases with polymers containing acid groups

Country Status (5)

Country Link
JP (1) JPS5254014A (en)
CH (1) CH621940A5 (en)
DE (1) DE2636559C2 (en)
IL (1) IL50250A (en)
SE (1) SE7609339L (en)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6056684B2 (en) * 1977-11-07 1985-12-11 東興薬品工業株式会社 eye drops
GB2013084B (en) * 1978-01-25 1982-07-28 Alcon Lab Inc Ophthalmic drug dosage
HU187313B (en) * 1980-10-03 1985-12-28 Andras Sugar Dental cosmetic prparation
IL61721A (en) * 1980-12-16 1984-03-30 Blank Izhak Nitroglycerin preparations
US4539199A (en) * 1981-01-14 1985-09-03 Egyt Gyogyszervegyeszeti Gyar Sustained release pharmaceutical compositions
EP0103970A3 (en) * 1982-08-20 1985-05-22 LAWRENCE, Peter Robin Broughton Amine salts and products containing them
AU563054B2 (en) * 1984-10-24 1987-06-25 Sekisui Kagaku Kogyo Kabushiki Kaisha Percutaneous tape of isdn
CA1295941C (en) * 1985-08-16 1992-02-18 Rajan Bawa Sustained-release formulation comprising a hydrophobic polymer system
JPS63503540A (en) * 1986-05-29 1988-12-22 フセソユーズヌイ、ナウチノ‐イスレドワーチェルスキー、イ、イスピタテルヌイ、インスチツート、メディツィンスコイ、チェフニキ Anti-tumor film made of biodegradable polymer
DE19508029C2 (en) * 1995-03-07 1997-10-09 Richard Prof Dr Sueverkruep Dosage form for external application of ophthalmic medicinal substances and method for the production thereof
US5972326A (en) * 1995-04-18 1999-10-26 Galin; Miles A. Controlled release of pharmaceuticals in the anterior chamber of the eye
US5888494A (en) * 1996-03-12 1999-03-30 Adolor Corporation Film-forming compositions of antihyperalgesic opiates and method of treating hyperalgesic and pruritic conditions therewith
EP0934082B1 (en) * 1996-10-23 2002-07-17 SKW Trostberg Aktiengesellschaft Process for producing biologically active polymer nanoparticle-nucleic acid conjugates
DE19753298A1 (en) * 1997-12-01 1999-06-02 Basf Ag Process for the preparation of solid dosage forms
DK172900B1 (en) * 1998-12-18 1999-09-27 Per Julius Nielsen Preparation and kit for use in intraocular surgery
JP5209827B2 (en) * 2011-03-18 2013-06-12 株式会社シード Drug sustained-release medical device
JP2017080303A (en) * 2015-10-30 2017-05-18 日油株式会社 Medicine sustained release medical use contact lens
SG11202004019SA (en) 2017-11-17 2020-05-28 Cellix Bio Private Ltd Compositions and methods for the treatment of eye disorders

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2229984A1 (en) * 1972-06-20 1974-01-10 Kraemer Kg Wilhelm FASTENING DEVICE FOR A BATTERY-FEED WARNING LAMP
DE2246037B2 (en) * 1972-09-20 1975-02-27 Taeschner & Co, 8831 Kipfenberg Orally applicable drug with delayed absorption in suspension form

Also Published As

Publication number Publication date
JPS5254014A (en) 1977-05-02
IL50250A (en) 1980-01-31
DE2636559C2 (en) 1985-10-31
CH621940A5 (en) 1981-03-13
SE7609339L (en) 1977-02-28
DE2636559A1 (en) 1977-03-17

Similar Documents

Publication Publication Date Title
IL50250A0 (en) Pharmaceutical base salts of a polymer containing acid
PH12825A (en) A method of preparing solid pharmaceutical dosage forms
ZA761413B (en) Preparation of solution polymers
JPS51118839A (en) Amino acid pharmacy for liverish patient dosage
FR2326934A1 (en) NEW PHARMACEUTICAL COMPOSITION BASED ON SERUM-ALBUMIN SPHERULES CONTAINING A MEDICINAL PRODUCT
ZA762285B (en) New phenyl-alkane-carboxylic acid derivatives
PH14489A (en) Manufacture of pharmaceutical dosage form
US6031093C1 (en) Solid salts of clavulanic acid
JPS5212134A (en) Compositions containing organicctitanic acid salts
NZ180552A (en) Pharmaceutical preparation containing a rigid macrom-orphological structure and a carbonxylic polymer or a salt there of
NO146044C (en) PROCEDURE FOR PREPARING A PHARMACEUTICAL INSULIN PREPARATION FOR RECTAL USE
BE827677A (en) CAPSULE COATING PROCESS
ZA765531B (en) New phenoxyalkylcarboxylic acid derivatives
ZA766183B (en) New phenoxyalkylcarboxylic acid derivatives
YU126276A (en) Process for preparing new propargyl-2-phenylamino-imidazolines-(2) and acid addition salts thereof
IL52433A0 (en) A novel 2-phenylimino-imidazolidine derivative and salts thereof their preparation and pharmaceutical compositions containing them
FR2308639A1 (en) STABLE SOLUTION OF A COENZYME
FR2325374A1 (en) NEW BASIC SUBSTITUTE PYRIDINECARBOXAMIDES USEFUL AS MEDICINAL PRODUCTS
HU173475B (en) Process for preparing a stable pharmaceutical preparation containing watre-soluble salts of parenterally applicable dehydro-epi-androsterone-sulphate
ZA762088B (en) Carboxylic acid amides a process for their preparation and their use as medicaments
FR2307541A1 (en) MEDICINAL PRODUCT BASED ON A POLYPEPTIDE
FR2313075A1 (en) MEDICINAL PRODUCT BASED ON L-PYROGLUTAMYL-L-HISTIDYL-L-PROLINAMIDE OR ITS SALTS
ZA76150B (en) Pharmaceutical ferrocene compound
IL47103A0 (en) 5-oxo-5h-dibenzo(a,d)-cycloheptene-2-acetic acid derivatives and salts and esters,their preparation and pharmaceutical compositions containing them
JPS5219650A (en) Novel diaminooandrostane derivatives * acid adduct salts * quartanary salts and preparation thereof